Prognostic Significance of Dicer Cellular Levels in Soft Tissue Sarcomas

REFERENCES

• Fletcher CDM, Rydholm A, Singer S, Sundaram M, Coindre JM. Soft Tissue Tumors: Epidemiology, Clinical Features, Histopathological Typing and Grading. Lyon, France: IARC Press, 2002.
   Google Scholar
• Clark MA, Fisher C, Judson I, Thomas JM. Soft tissue sarcomas in adults. N Eng J Med 2005;353:701–711.
   PubMed Web of Science ®Google Scholar
• Olsen RJ, Tarantolo SR, Hinrichs SH. Molecular approaches to sarcoma therapy. Sarcoma 2002;6:27–42.
   PubMedGoogle Scholar
• Coindre JM, Trojani M, Contesso G, David M, Rouesse J, Bui NB, Bodaert A, De Mascarel I, De Mascarel A, Goussot JF. Reproducibility of a histopathologic grading system for adult soft tissue sarcomas. Cancer 1986;58:306–309.
   PubMed Web of Science ®Google Scholar
• Verweij J, Baker LH. Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular abberations. Eur J Cancer 2010;46:863–868.
   PubMed Web of Science ®Google Scholar
• Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009;136:642–645.
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature 2009;431:343–349.
   Google Scholar
• Drakaki A, Iliopoulos D. MicroRNA gene networks in oncogenesis. Curr Genomics 2009;10:35–41.
   PubMed Web of Science ®Google Scholar
• Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005;65:3509–3512.
   PubMed Web of Science ®Google Scholar
• Croce CM, Calin GA. MicroRNAs, cancer, and stem cell division. Cell 2005;122:6–7.
   PubMed Web of Science ®Google Scholar
• Babashah S, Soleimani M. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 2011;47:1127–1137.
   PubMed Web of Science ®Google Scholar
• Chiosea S, Jelezcova E, Chandran U, Luo J, Mantha G, Sobol RW, Dacic S. Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res 2007;67:2345–2350.
   PubMed Web of Science ®Google Scholar
• Grelier G, Voirin N, Ay AS, Cox DG, Chabaud S, Treilleux I, Léon-Goddard S, Rimokh R, Mikaelian I, Venoux C, Puisieux A, Lasset C, Moyret-Lalle C. Prognostic value of Dicer in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 2009;101:673–683.
   PubMed Web of Science ®Google Scholar
• Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK. Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 2008;359:2641–2650.
   PubMed Web of Science ®Google Scholar
• Flavin RJ, Smyth PC, Finn SR, Laios A, O'Toole SA, Barrett C, Ring M, Denning KM, Li J, Aherne ST, Aziz NA, Alhadi A, Sheppard BL, Loda M, Martin C, Sheils OM, O'Leary JJ. Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients. Mod Pathol 2008;21:676–684.
   PubMed Web of Science ®Google Scholar
• Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol RW, Dhir R. Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am J Pathol 2006;169:1812–1820.
   PubMed Web of Science ®Google Scholar
• Chiosea SI, Barnes EL, Lai SY, Egloff AM, Sargent RL, Hunt JL, Seethala, RR. Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of dicer expression. Virchows Arch 2008;452:629–635.
   PubMed Web of Science ®Google Scholar
• Zhang X, Cairns M, Rose B, O'Brien C, Shannon K, Clark J, Gamble J, Tran N. Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer 2009;124:2855–2863.
   PubMed Web of Science ®Google Scholar
• Faber C, Horst D, Hlubek F, Kirchner T. Overexpression of Dicer predicts poor survival in colorectal cancer. Eur J Cancer 2011;47:1414–1419.
   PubMed Web of Science ®Google Scholar
• Papachristou DJ, Korpetinou A, Giannopoulou E, Antonacopoulou AG, Papadaki H, Grivas P, Scopa CD, Kalofonos HP. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Arch 2011;459:431–440.
   PubMed Web of Science ®Google Scholar
• McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Urol 2005;2:416–422.
   PubMedGoogle Scholar
• Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C. Soft tissue sarcomas of adults; study of pathological prognostic variables and definition of histopathological grading system. Int J Cancer 1984;33:37–42.
   PubMed Web of Science ®Google Scholar
• Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology 2006;48:42–50.
   PubMed Web of Science ®Google Scholar
• Rao UN, Finkelstein SD, Jones MW. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas. Mod Pathol 1999;12:1001–1009.
   PubMed Web of Science ®Google Scholar
• Ren B, Yu YP, Jing L, Liu L, Michalopoulos GK, Luo JH, Rao UN. Gene expression analysis of human soft tissue leiomyosarcomas. Hum Pathol 2003;34:449–458.
   Google Scholar
• Masciullo V, Berardengo E, Boglione A, Sgambato A, Bernardi A, Forni M, Linari A, Cito L, Scambia G, Comandone A, Giordano A. The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas. Clin Cancer Res 2008;14:4775–4779.
   PubMed Web of Science ®Google Scholar
• Tomita Y, Morooka T, Hoshiba Y, Zhang B, Qiu Y, Nakamichi I, Hamada K, Ueda T, Naka N, Kudawara I, Aozasa K. Prognostic significance of activated AKT expression in soft-tissue sarcoma. Clin Cancer Res 2006;12:3070–3077.
   PubMed Web of Science ®Google Scholar
• Papachrtistou DJ, Gkretsi V, Tu Y, Shi X, Chen K, Larjava H, Rao UN, Wu C. Increased cytoplasmic level of migfilin is associated with higher grades of human leiomyosarcoma. Histopathology 2007;51:499–508.
   PubMed Web of Science ®Google Scholar
• Steigen SE, Schaefer DF, West RB, Nielsen TO. Expression of insulin-like growth Factor 2 in mesenchymal neoplasms. Mod Pathol 2009;22:914–921.
   PubMed Web of Science ®Google Scholar
• Ahrens WA, Ridenour RVR, III, Caron BL, Miller DV, Folpe AL. GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms. Hum Pathol 2008;39:1519–1526.
   PubMed Web of Science ®Google Scholar
• Mikuma T, Kawasaki H, Yamamoto Y, Taira K. Overexpression of Dicer enhances RNAi-mediate gene silencing by short-hairpin RNAs (shRNAs) in human cells. Nucleic Acids Symp Ser (Oxf) 2004;48:191–192.
   PubMedGoogle Scholar